According to BioLineRx's latest financial reports the company has a price-to-book ratio of 0.356157.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.66 | -79.84% |
2023-12-31 | 8.25 | 1044.49% |
2022-12-31 | 0.7211 | -50.62% |
2021-12-31 | 1.46 | -46.23% |
2020-12-31 | 2.72 | 240.7% |
2019-12-31 | 0.7972 | -33.9% |
2018-12-31 | 1.21 | -44.32% |
2017-12-31 | 2.17 | 48.81% |
2016-12-31 | 1.46 | -3.55% |
2015-12-31 | 1.51 | -25.81% |
2014-12-31 | 2.03 | -64.99% |
2013-12-31 | 5.81 | 87.94% |
2012-12-31 | 3.09 | 77.75% |
2011-12-31 | 1.74 |